PERIPHERAL NERVOUS SYSTEM LESSON IN CORONAVIRUS INFECTION COVID-19

Authors

  • Ya.N. Majidova Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan
  • N.M. Azimova, Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan
  • M.K. Temirova Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan

Keywords:

Infection, coronavirus, PNS,, tremor, myelitis, encephalopathy, anosmia, dysgeusia,, Hyena-Barre cider

Abstract

Infection caused by the SARS-CoV-2 (COVID-19) coronavirus, accompanied by various lesions of various organs and body systems, is associated with a certain level of mortality, especially in the presence of risk factors [1]. The interest of neurologists in this disease is due to the frequent defeat of various parts of the central and peripheral nervous system (PNS), reports of which appeared in the medical literature already in the first half of 2020.

Downloads

Download data is not yet available.

References

Bello-cHavolla O., Bahena-Lopez J., Antonio-Villa N., etc. Predicting SARS-CoV-2 mortality: A mechanistic assessment linking obesity and diabetes to COVID-19 outcomes in Mexico. J Clinical Endocrinol Metab. 2020;105(8):dgaa346. DOI:10.1210/clinem/dgaa346.

Uncini A., Vallat J.-M., Jacobs B.K. Guillain-Barre syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of the pandemic. J Neurosurgery Psychiatry. 2020;91(10):1105-1110. DOI: 10.1136/jnnp-2020-324491.

Abu-Rumeile S., Abdelhak A., Foski M. The spectrum of Guillain-Barre syndrome associated with COVID-19: a modern systematic review of 73 cases. J Neurol. 2020;1-38. DOI: 10.1007/s00415-020-10124- x. Online is ahead of print.

Fragiel M., Miro O., Llorens P. et al. Morbidity, clinical manifestations, risk factors and outcomes of Guillain-Barre disease in Covid-19. Ann Neuro, 2020. DOI: 10.1002/ana.25987. Online is ahead of print.

Rinaldi S. Coronavirus disease of 2019 and the risk of Guillain-Barre syndrome. Ann Neuro. 2021 January 4. DOI: 10.1002/ana.26011. Online is ahead of print.

Hassan I., Saif-Ur-Rahman K.M., Hayat S. et al. Guillain-Barre syndrome associated with SARS-CoV-2 infection: a systematic review and meta-analysis of data from individual participants. J Peripheral nervous system. 2020;25:335-343. DOI:10.1111/jns.12419.

Horby P., Landari M. Recovery test, 2020. (Electronic resource.) URL: https://www.recoverytrial.net (accessed: 06/02/2020).

Willison H., Jacobs B., van Dorn A. Guillain-Barre syndrome. The Lancet. 2016;388:717-727.DOI:10.1016/S0140-6736(16)00339-1.

Falcone M., Rong A., Salazar H. et al. Acute paralysis of the abductor nerves in a patient with a new coronavirus disease (COVID-19). Acute paralysis of the abductor nerves in a patient with a new coronavirus disease (COVID-19). JAAPOS. 2020;24(4):216-217. DOI:10.1016/j.jaapos.2020.06.001.

Raharimanantsoa O., Razakarivoni F., Andriamiadanalisoa A. et al. Multinévrite oculaire dans le cadre d'une infection COVID-19 Multiple infectious cranial nerve paralysis in COVID-19. J Fr Ophthalmol. 2020;43(10): e351–e353. DOI: 10.1016/j.jfo.2020.08.001.

Raakhimi M., Kane A., Moore S., Alarid A. Late onset of Guillain-Barre syndrome after SARS-CoV-2 infection: part of the 'long-term COVID-19 syndrome'? BMJ case, Rep. 2021;14: e240178. DOI: 10.1136/bcr-2020-240178.

Downloads

Published

2021-11-09

How to Cite

Ya.N. Majidova, N.M. Azimova, & M.K. Temirova. (2021). PERIPHERAL NERVOUS SYSTEM LESSON IN CORONAVIRUS INFECTION COVID-19. International Scientific and Current Research Conferences, 1(01), 81–84. Retrieved from https://orientalpublication.com/index.php/iscrc/article/view/119